Opthea Ltd (CKDXF) stock
CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Opthea operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$155.76M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -$155.76M | – |
| FY2024 | Jun 30, 2024 | -$191.84M | – |
| FY2023 | Jun 30, 2023 | -$150.03M | – |
| FY2022 | Jun 30, 2022 | -$96.54M | – |
See a number that looks wrong?